January 11, 2010 - The board of directors of a hand-carried ultrasound manufacturer, SonoSite Inc., authorized the repurchase of up to $150 million of the company’s common stock or outstanding convertible notes for cash.

In connection with the repurchase authorization, the company will purchase up to $100 million of the company’s common stock through a modified “Dutch Auction” tender offer. SonoSite intends to commence the tender offer during the week of January 18, 2010. The move will benefit stockholders by providing liquidity at a premium over current trading prices.

Under the terms of the proposed tender offer, SonoSite shareholders will have the opportunity to tender some or all of their shares at a price within the range of $26.10 to $30.00 per share. Based on the number of shares tendered and the prices specified by the tendering shareholders, SonoSite will determine the lowest per-share price within the range that will enable it to buy $100 million in shares, or such lesser number of shares that are properly tendered.

All shares accepted for payment will be paid the same price, regardless of whether a shareholder tendered such shares at a lower price within the range. At the minimum price of $26.10 per share, SonoSite would repurchase a maximum of 3,831,417 shares, which represents approximately 22 percent of SonoSite’s currently outstanding common stock. SonoSite will fund the repurchase from available cash on hand.

The low and high ends of the price range represent approximately a 0 percent and 15 percent premium, respectively, to the most recent share closing price of $26.10 per share. Based on the January 8, 2010, closing price, the share price has increased 10 percent year-to-date.

For more information: www.sonosite.com


Related Content

News | Point-of-Care Ultrasound (POCUS)

June 17, 2025 — Royal Philips has announced the global launch of the Flash Ultrasound System 5100 POC — a new point-of ...

Time June 19, 2025
arrow
News | Lung Imaging

June 18, 2025 — Exo recently announced that now included on its Exo Iris is the first ever FDA 510(k) cleared AI for ...

Time June 18, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

April 16, 2025 — An artificial intelligence (AI) program trained to review images from a common medical test can detect ...

Time April 16, 2025
arrow
News | Ultrasound Women's Health

April 11, 2025 — Contrast-enhanced ultrasound (CEUS) is a safe and accurate diagnostic imaging option for pregnant women ...

Time April 11, 2025
arrow
News | Focused Ultrasound Therapy

March 31, 2025 — Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage ...

Time April 02, 2025
arrow
News | Breast Imaging

March 20, 2025 — GE HealthCare has launched Invenia Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound ...

Time March 21, 2025
arrow
News | X-Ray

March 18, 2025 — GE HealthCare recently announced a collaboration with NVIDIA expanding the existing relationship ...

Time March 19, 2025
arrow
News | Breast Imaging

Feb. 26, 2025 — iCAD, Inc. a provider of clinically proven AI-powered cancer detection solutions, and Koios Medical, a ...

Time March 03, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
Subscribe Now